[Antibody-dependent cell-mediated cytotoxicity (ADCC) in patients with sarcoidosis (author's transl)]. 1980

Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura

UI MeSH Term Description Entries
D007703 Peptidyl-Dipeptidase A A peptidyl-dipeptidase that catalyzes the release of a C-terminal dipeptide, oligopeptide-|-Xaa-Yaa, when Xaa is not Pro, and Yaa is neither Asp nor Glu. Thus, conversion of ANGIOTENSIN I to ANGIOTENSIN II, with increase in vasoconstrictor activity, but no action on angiotensin II. It is also able to inactivate BRADYKININ, a potent vasodilator; and has a glycosidase activity which releases GPI-anchored proteins from the membrane by cleaving the mannose linkage in the GPI moiety. (From https://www.uniprot.org April 15, 2020). ACE1 Angiotensin-Converting Enzyme 1,ACE1 Protein,Angiotensin Converting Enzyme,Angiotensin Converting Enzyme 1,Antigens, CD143,CD143 Antigens,Dipeptidyl Carboxypeptidase I,Kininase II,Peptidase P,Angiotensin I-Converting Enzyme,Carboxycathepsin,Dipeptidyl Peptidase A,Kininase A,ACE1 Angiotensin Converting Enzyme 1,Angiotensin I Converting Enzyme,Carboxypeptidase I, Dipeptidyl,Peptidyl Dipeptidase A
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009113 Muramidase A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17. Lysozyme,Leftose,N-Acetylmuramide Glycanhydrolase,Glycanhydrolase, N-Acetylmuramide,N Acetylmuramide Glycanhydrolase
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell
D012507 Sarcoidosis An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands. Besnier-Boeck Disease,Boeck's Sarcoid,Besnier-Boeck-Schaumann Syndrome,Boeck Disease,Boeck's Disease,Schaumann Disease,Schaumann Syndrome,Schaumann's Syndrome,Besnier Boeck Disease,Besnier Boeck Schaumann Syndrome,Boeck Sarcoid,Boecks Disease,Boecks Sarcoid,Disease, Schaumann,Sarcoid, Boeck's,Sarcoidoses,Schaumann's Syndromes,Syndrome, Besnier-Boeck-Schaumann,Syndrome, Schaumann,Syndrome, Schaumann's

Related Publications

Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura
January 1980, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura
November 1999, Nihon rinsho. Japanese journal of clinical medicine,
Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura
June 2010, Nihon rinsho. Japanese journal of clinical medicine,
Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura
January 1980, Annales d'immunologie,
Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura
August 1977, Nippon Ganka Gakkai zasshi,
Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura
July 2005, Nihon rinsho. Japanese journal of clinical medicine,
Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura
January 1983, Nihon rinsho. Japanese journal of clinical medicine,
Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura
March 1993, Journal of the neurological sciences,
Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura
January 1979, Archives of virology,
Y Ina, and M Yamamoto, and K Takada, and T Sugiura, and T Suzuki, and M Morishita, and H Aoki, and Y Torii, and K Ichimura
November 1987, Veterinary immunology and immunopathology,
Copied contents to your clipboard!